Innate Pharma S.A. (IPH.PA) - Balance Sheet Statement

Home
IPH.PA
Financials

1.616 (EUR) • At close November 13, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005
Assets:
Current Assets:
Cash & Cash Equivalents Numbers are in millions	70.605	84.225	103.756	136.792	202.887	152.314	99.367	175.906	152.87	64.286	38.36	30.584	46.606	31.818	46.448	10.885	2.482	6.159	2.586
Short Term Investments Numbers are in millions	21.851	17.26	16.08	14.845	15.978	15.217	16.743	21.782	83.04	4.952	2.989	2.032	0	2.763	2.746	22.947	48.301	53.664	15.757
Cash and Short Term Investments Numbers are in millions	92.456	101.485	119.836	151.637	218.865	167.531	116.11	197.688	235.91	69.238	41.349	32.616	46.606	34.581	49.194	33.832	50.783	59.823	18.343
Net Receivables Numbers are in millions	46.489	3.08	0.846	10.585	2.816	146.637	15.084	25.554	9.948	0.426	1.993	2.632	0	5.107	5.981	13.86	2.316	2.426	0
Inventory Numbers are in millions	0	-0.002	-4.946	0	5.6	0	6.328	0.513	0.278	1.49	0.94	1.151	0	0	0	0	0	0	0
Other Current Assets Numbers are in millions	9.067	35.266	17.574	12.343	15.924	5.475	6.327	6.323	5.99	1.49	6.187	1.151	0.581	0	1.091	4.36	2.358	2.024	1.615
Total Current Assets Numbers are in millions	148.012	139.831	138.256	173.332	237.605	319.643	137.521	230.078	252.126	79.314	49.35	40.997	52.975	40.664	56.266	52.209	55.595	64.273	21.209
Non-Current Assets:
Property, Plant & Equipment, Net Numbers are in millions	6.322	8.542	10.174	11.694	11.672	10.216	10.729	9.094	6.304	5.931	6.258	6.824	6.442	7.335	7.943	8.523	1.517	0.774	0.707
Goodwill Numbers are in millions	0	-40.997	0.002	0.001	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Intangible Assets Numbers are in millions	0.416	42.553	44.19	46.288	96.967	84.529	46.192	9.075	9.732	5.362	0	0	0	0	0	0	0	0	0
Goodwill and Intangible Assets Numbers are in millions	0.416	1.556	44.192	46.289	96.967	84.529	46.192	9.075	9.732	5.362	0	0	0	0	0	0	0	0	0
Long Term Investments Numbers are in millions	9.796	35.119	39.878	38.934	37.005	35.181	60.469	32.975	37.794	0.084	0.272	0.475	0	0	0	0	0	0	0
Tax Assets Numbers are in millions	9.006	8.568	5.028	7.087	1.286	1.561	0	0	-37.794	-0.084	0	0	0	0	0	0	0	0	0
Other Non-Current Assets Numbers are in millions	10.641	14.248	29.969	30.087	16.826	0.087	0.111	0.355	37.794	0.084	0.002	0	0.692	0.011	0.01	0.13	6.041	4.208	2.851
Total Non-Current Assets Numbers are in millions	36.181	68.033	129.241	134.091	163.756	131.574	117.501	51.499	53.83	11.377	6.532	7.299	7.134	7.346	7.953	8.653	7.558	4.982	3.558
Total Assets Numbers are in millions	184.193	207.863	267.496	307.423	401.361	451.216	255.023	281.577	305.956	90.69	55.882	48.295	60.109	48.01	64.219	60.862	63.153	69.255	24.767
Liabilities & Equity:
Current Liabilities:
Account Payables Numbers are in millions	8.561	13.656	14.729	20.73	27.936	28.576	19.97	15.599	8.618	6.846	5.141	4.67	4.202	5.031	6.022	6.575	5.089	2.896	2.03
Short Term Debt Numbers are in millions	8.936	2.102	30.748	2.142	2.13	1.347	1.343	1.264	0.622	0.453	0.613	1.178	2.273	0.701	0	0	0	0.585	0.169
Tax Payables Numbers are in millions	7.021	5.978	7.463	8.325	6.999	5.661	4.404	4.391	0	2.386	2.092	1.711	0	0	0	0	0	1.191	0.597
Deferred Revenue Numbers are in millions	5.865	6.56	12.5	12.505	48.77	82.096	47.909	54.912	-44.434	0.885	1.259	7.663	0	-0.688	-0.55	0	0	1.191	0.597
Other Current Liabilities Numbers are in millions	9.254	13.042	14.446	14.291	35.987	79.057	0.283	0.275	10.013	1.09	1.432	7.805	9.019	1.642	3.243	6.244	5.457	5.365	-0.536
Total Current Liabilities Numbers are in millions	39.637	41.338	79.886	46.694	121.822	196.737	73.909	76.441	60.163	10.775	9.278	15.364	15.494	7.374	9.265	12.819	10.546	10.037	2.26
Non-Current Liabilities:
Long Term Debt Numbers are in millions	30.957	40.149	13.503	16.945	16.593	3.175	4.521	4.063	3.132	3.753	4.206	3.327	4.497	2.435	2.448	0	0	2.723	0.411
Deferred Revenue Non-Current Numbers are in millions	4.618	7.921	25.413	31.469	40.342	68.098	87.005	112.348	0	0	0	0	0	0	0	0	0	0	0
Deferred Tax Liabilities Non-Current Numbers are in millions	9.006	8.568	5.028	7.087	1.286	1.561	3.633	2.554	0	0	0	0	0	0	0	0	0	0	0
Other Non-Current Liabilities Numbers are in millions	48.074	55.736	36.226	49.253	3.902	14.405	3.632	112.35	170.594	1.536	2.112	6.24	13.493	4.685	5.384	6.702	3.001	0.126	2.031
Total Non-Current Liabilities Numbers are in millions	92.655	112.374	80.17	104.754	62.123	87.239	95.158	118.967	173.726	5.289	6.318	9.567	17.99	7.12	7.832	6.702	3.001	2.849	2.442
Total Liabilities Numbers are in millions	132.292	153.712	160.056	151.448	183.945	283.976	169.067	195.408	233.889	16.064	15.596	24.931	33.484	14.494	17.097	19.521	13.547	12.886	4.702
Equity:
Preferred Stock Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Numbers are in millions	4.044	4.011	3.978	3.95	3.941	3.197	2.88	2.696	2.692	2.648	2.287	1.897	1.884	1.884	1.832	1.296	1.259	1.249	0.745
Retained Earnings Numbers are in millions	-336.893	-330.316	-272.213	-220.46	-155.671	-134.791	-151.98	-103.595	-116.231	-109.528	-89.964	-87.069	-6.98	-76.883	-63.223	-44.06	-34.461	-26.145	-19.769
Accumulated Other Comprehensive Income/Loss Numbers are in millions	0.495	0.819	0.456	0.355	-0.472	-1.099	0.18	-0.503	-0.73	-0.241	-0.038	-0.017	0	0.341	0.219	0	0	0	0
Other Total Stockholders Equity Numbers are in millions	384.255	379.637	375.22	372.131	369.617	299.932	234.876	187.571	186.337	181.746	128	108.552	108.624	108.173	108.295	87.691	82.808	81.265	39.089
Total Shareholders Equity Numbers are in millions	51.901	54.151	107.44	155.975	217.416	167.24	85.956	86.169	72.067	74.626	40.286	23.364	26.625	33.516	47.122	41.341	49.606	56.369	20.065
Total Equity Numbers are in millions	51.901	54.151	107.44	155.975	217.416	167.24	85.956	86.169	72.067	74.626	40.286	23.364	26.625	33.516	47.122	41.341	49.606	56.369	20.065
Total Liabilities & Shareholders Equity Numbers are in millions	184.193	207.863	267.496	307.423	401.361	451.216	255.023	281.577	305.956	90.69	55.882	48.295	60.109	48.01	64.219	60.862	63.153	69.255	24.767

Innate Pharma S.A.

EPA:IPH.PA Add to watchlist

EPA:IPH.PA